Pfizer and Bristol-Myers Squibb (BMS): Grant program
| Name: |
Pfizer and Bristol-Myers Squibb (BMS): Grant program Application deadline: 06/05/24 |
|---|---|
| General description: |
To enhance understanding of the oral anticoagulant treatment of patients with atrial fibrillation and/or venous thromboembolism. Grant proposals should leverage innovative data and content delivery mechanisms including an omnichannel approach. Requests for regional/multi-country educational proposals are within scope, however, single-country programs will not be considered. Funding: Up to $300K https://www.ra.trdf.co.il/files/GMG_2024_IM_PfizerBMSCVIME.pdf |
| Source: | Foreign |
| Participating Countries: | All Countries, |
| Budget: | Up to $300K |
| Contact person: | Robi, 2152, robertg@trdf.technion.ac.il; iris 1272, irisbr@technion.ac.il; Luba, lubak@technion.ac.il |
| Fields: | Life Sciences and medicine,Social Sciences and humanities |
| Type of fund: | The fund is not a competitive fund |
| Related fund and profiles: | Pfizer ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner) |